Muscle loss during GLP-1 weight loss is typically linked to: Low protein intake Large calorie deficits Reduced resistance training Rapid or unstructured weight loss Weight loss always includes a mix of fat and lean mass loss, but research on GLP-1 medications suggests that while fat loss is predominant, some lean mass loss can occur depending on dietary intake and physical activity levels
Common side effects of GLP-1 include nausea, diarrhea, vomiting, constipation, stomach pain/discomfort, decreased appetite, and indigestion
As a GLP-1 receptor agonist, it works with your bodys natural hunger signals regulating appetite, slowing digestion, and supporting healthier blood sugar levels
We included patients aged 18 years with a diagnosis of diabetes previously recorded in EHR encounters who were newly prescribed add-on non-insulin glucose-lowering agents and were on metformin between 2005 and 2020
Originally developed to treat type 2 diabetes, these injectable medications have been found to support substantial weight loss by influencing the bodys natural signals for hunger and satiety
John Salerno What is GLP-1 Therapy